2wbd: Difference between revisions

← Older edit

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2wbd.png|left|200px]]
-{{STRUCTURE_2wbd|  PDB=2wbd  |  SCENE=  }}
+==FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH AN AMP SITE INHIBITOR==
+<StructureSection load='2wbd' size='340' side='right'caption='[[2wbd]], [[Resolution|resolution]] 2.40&Aring;' scene=''>
+== Structural highlights ==
+<table><tr><td colspan='2'>[[2wbd]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2WBD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2WBD FirstGlance]. <br>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.4&#8491;</td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=RO5:N-[(5-BROMO-1,3-THIAZOL-2-YL)CARBAMOYL]-3-ETHYLBENZENESULFONAMIDE'>RO5</scene></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2wbd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2wbd OCA], [https://pdbe.org/2wbd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2wbd RCSB], [https://www.ebi.ac.uk/pdbsum/2wbd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2wbd ProSAT]</span></td></tr>
+</table>
+== Disease ==
+[https://www.uniprot.org/uniprot/F16P1_HUMAN F16P1_HUMAN] Defects in FBP1 are the cause of fructose-1,6-bisphosphatase deficiency (FBPD) [MIM:[https://omim.org/entry/229700 229700]. FBPD is inherited as an autosomal recessive disorder mainly in the liver and causes life-threatening episodes of hypoglycemia and metabolic acidosis (lactacidemia) in newborn infants or young children.<ref>PMID:9382095</ref> <ref>PMID:12126934</ref>
+== Function ==
+[https://www.uniprot.org/uniprot/F16P1_HUMAN F16P1_HUMAN]
+== Evolutionary Conservation ==
+[[Image:Consurf_key_small.gif|200px|right]]
+Check<jmol>
+  <jmolCheckbox>
+    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/wb/2wbd_consurf.spt"</scriptWhenChecked>
+    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
+    <text>to colour the structure by Evolutionary Conservation</text>
+  </jmolCheckbox>
+</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2wbd ConSurf].
+<div style="clear:both"></div>
+<div style="background-color:#fffaf0;">
+== Publication Abstract from PubMed ==
+Sulfonylureido thiazoles were identified from a HTS campaign and optimized through a combination of structure-activity studies, X-ray crystallography and molecular modeling to yield potent inhibitors of fructose-1,6-bisphosphatase. Compound 12 showed favorable ADME properties, for example, F=70%, and a robust 32% glucose reduction in the acute db/db mouse model for Type-2 diabetes.
-===FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1-PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH AN AMP SITE INHIBITOR===
+Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.,Kitas E, Mohr P, Kuhn B, Hebeisen P, Wessel HP, Haap W, Ruf A, Benz J, Joseph C, Huber W, Sanchez RA, Paehler A, Benardeau A, Gubler M, Schott B, Tozzo E Bioorg Med Chem Lett. 2010 Jan 15;20(2):594-9. Epub 2009 Nov 22. PMID:19969452<ref>PMID:19969452</ref>
-{{ABSTRACT_PUBMED_19969452}}
+From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
+</div>
-==About this Structure==
+<div class="pdbe-citations 2wbd" style="background-color:#fffaf0;"></div>
-[[2wbd]] is a 8 chain structure of [[Fructose-1%2C6-bisphosphatase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2WBD OCA].
 ==See Also==
-*[[Fructose-1%2C6-bisphosphatase|Fructose-1%2C6-bisphosphatase]]
+*[[Fructose-1%2C6-bisphosphatase 3D structures|Fructose-1%2C6-bisphosphatase 3D structures]]
+== References ==
-==Reference==
+<references/>
-<ref group="xtra">PMID:019969452</ref><references group="xtra"/>
+__TOC__
-[[Category: Fructose-bisphosphatase]]
+</StructureSection>
 [[Category: Homo sapiens]]
-[[Category: Benz, J.]]
+[[Category: Large Structures]]
-[[Category: Bernadeau, A.]]
+[[Category: Alvarez Sanchez R]]
-[[Category: Fol, B.]]
+[[Category: Benz J]]
-[[Category: Gubler, M.]]
+[[Category: Bernadeau A]]
-[[Category: Haap, W.]]
+[[Category: Fol B]]
-[[Category: Hebeisen, P.]]
+[[Category: Gubler M]]
-[[Category: Huber, W.]]
+[[Category: Haap W]]
-[[Category: Joseph, C.]]
+[[Category: Hebeisen P]]
-[[Category: Kitas, E.]]
+[[Category: Huber W]]
-[[Category: Kuhn, B.]]
+[[Category: Joseph C]]
-[[Category: Mohr, P.]]
+[[Category: Kitas E]]
-[[Category: Paehler, A.]]
+[[Category: Kuhn B]]
-[[Category: Ruf, A.]]
+[[Category: Mohr P]]
-[[Category: Sanchez, R Alvarez.]]
+[[Category: Paehler A]]
-[[Category: Schott, B.]]
+[[Category: Ruf A]]
-[[Category: Tetaz, T.]]
+[[Category: Schott B]]
-[[Category: Tozzo, E.]]
+[[Category: Tetaz T]]
-[[Category: Wessel, H P.]]
+[[Category: Tozzo E]]
-[[Category: Allosteric enzyme]]
+[[Category: Wessel HP]]
-[[Category: Carbohydrate metabolism]]
-[[Category: Gluconeogenesis]]
-[[Category: Hydrolase]]
-[[Category: Phosphoric monoester]]